WebThe combined on-exchange and off-exchange short sale volume for CYCN / Cyclerion Therapeutics Inc is provided in the table below. In order to calculate an accurate short volume ratio, we gather data from a number of trading venues, but not ALL trading venues. WebNov 22, 2024 · The Investor Relations website contains information about Cyclerion Therapeutics, Inc.'s business for stockholders, potential investors, and financial … CNS is a high-reward space with large and growing unmet need due to an aging … Leveraging a Critical Pathway. Cyclerion was founded with the goal of unlocking … Culture & Careers. We have an exceptional team at Cyclerion with a vibrant and … Investor Resources; Culture & Careers; Our Commitment. We are committed to …
MSN
WebCyclerion Investor Relations Team: [email protected] Auditors: Ernst & Young 200 Clarendon Street Boston, MA 02116 617.266.2000 Transfer Agent: Computershare Investor Services PO Box 43006 Providence, RI 02940-3078 Within USA, US … WebCyclerion Therapeutics Inc (NASDAQ:CYCN) institutional ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position … small offset
CYCN - Short Interest - Cyclerion Therapeutics Inc Stock
WebMay 9, 2024 · Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) shareholders (or potential shareholders) will be happy to see that the CEO & Director, Peter Hecht, recently bought a whopping US$1.7m worth of stock, at ... WebCAMBRIDGE, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (Nasdaq: CYCN) today announced that the Board of Directors of the Company acting … WebCYCN Institutional Holdings Ownership Summary Active Positions New and Sold Out Positions 55 Institutional Holders 21,001,047 Total Shares Held Back to CYCN Overview … highlight hockey